IRWD — Ironwood Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapNeutral

Annual balance sheet for Ironwood Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	177	363	620	656	92.2
Net Total Accounts Receivable
Net Total Receivables	117	122	114	115	129
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	307	496	745	781	233
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	30.2	25.5	22.9	20.3	18.2
Net Goodwill
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	403	559	1,127	1,101	471
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	40.9	32.2	162	25.5	276
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	496	497	521	448	817
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-93.3	62.6	606	652	-346
Total Liabilities & Shareholders' Equity	403	559	1,127	1,101	471
Total Common Shares Outstanding